Epidemiology of Chikungunya in the Americas

by Sergio Yactayo, J. Erin Staples, Véronique Millot et al.
J Infect Dis. (2016) 214 (suppl 5): S441-S445.

5 pp. 343 kB
http://jid.oxfordjournals.org/content/214/suppl_5/S441.full.pdf+htmlsuppl_5-cover

Chikungunya virus (CHIKV) emerged in the Americas in late 2013 to cause substantial acute and chronic morbidity. About 1.1 million cases of chikungunya were reported within a year, including severe cases and deaths. The burden of chikungunya is unclear owing to inadequate disease surveillance and under-diagnosis. Virus evolution, globalization, and climate change may further CHIKV spread. No approved vaccine or antiviral therapeutics exist. Early detection and appropriate management could reduce the burden of severe atypical and chronic arthritic disease. Improved surveillance and risk assessment are needed to mitigate the impact of chikungunya.

(Visited 15 times, 1 visits today)
This entry was posted in General, Other Infectious Diseases. Bookmark the permalink.